Sharyn Lewin

Dr. Sharyn Lewin, a leading gynecologic oncologist and Director of Gynecologic Oncology at Holy Name Medical Center, shares her expertise on ovarian cancer treatments. She emphasizes the critical role of surgical staging and debulking surgeries. The conversation includes insights on germline testing and the use of PARP inhibitors alongside bevacizumab. Dr. Lewin also discusses strategies for managing refractory disease and the importance of biomarker testing, particularly HRD status, for personalized treatment options.